FinTechFunding

Aro Biotherapeutics: Raises $88M in Series A Financing

  • Aro Biotherapeutics, a Philadelphia, PA-based biotechnology company pioneering the development of tissue-targeted genetic medicines, closed an $88m Series A financing
  • The round led by Northpond Ventures and Cowen Healthcare Investments, with participation from HealthCap, BVF Partners L.P., and Ridgeback Capital
  • The company also intends to use the funds to advance its lead therapeutic candidates into clinical development
  • Aro is developing a unique class of Centyrin-conjugated RNA therapies to efficiently and selectively target RNA medicines to the specific site of disease
  • Centyrins are small, stable, engineered human proteins with several properties that make them suited to target receptors on specific cells
  • Then the company is developing a wholly-owned pipeline of Centyrin-based therapeutic candidates
Previous article
Conotoxia: Launched MT4 platform
Next article
JPMorgan Chase: Acquires travel and loyalty business from cxLoyalty
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

SumUp Strengthens Merchant Services with In-App Investing Feature

The new feature aims to enhance financial flexibility for merchant clients.Highlights: SumUp introduces in-app investing for merchant clients.The...
FinTech

Aveni Selected by Quilter to Enhance Operations with AI

New partnership streamlines advice operations for Quilter using AI technology.Highlights: Quilter partners with Aveni to implement AI solutions.The...
FinTech

Venmo Strengthens Global Transfers by Allowing Payments to PayPal Accounts

Venmo users can now send money internationally to PayPal accounts.Highlights: Venmo now allows users to send money to...
FinTech

Talos and Nasdaq Strengthen On-Chain and Off-Chain Collateral Workflow

New partnership enhances digital asset handling and collateral management.Highlights: Talos and Nasdaq collaborate to streamline collateral workflows.Partnership aims...